Amgen and Merck initiate a collaborative study to evaluate the safety and efficacy of the former’s talimogene laherparepvec and the latter’s Keytruda (pembrolizumab) in patients with regionally or distantly metastatic melanoma.
MRV Research
Telomere Length Genes Are Associated With Melanoma Risk
Longer telomeres have been associated with increased risk of melanoma. In a GenoMEL Consortium genome-wide association study reported in the Journal of the National Cancer Institute, Iles et al found that several single-nucleotide polymorphisms (SNPs) previously associated with leukocyte telomere length were significantly associated with risk of melanoma.
Study Finds Proteomic Biomarkers in Metastatic Melanoma
In a recent study titled “Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation”, published in the PlosOne journal, a team of researchers led by Dr. Vito Michele Garrisi from the Istituto Tumori “Giovanni Paolo II”, Bari, Italy, sought to discover novel candidate biomarkers predictive of melanoma treatment.
Oncologists examine efficacy of rose bengal against cancer
Rose Bengal has been around for decades starting as a way to dye wool. Originally used in medicine as a stain for ophthalmologists, it has a solid safety record going back to the 1930s. Recently, oncologists have examined its efficacy against cancer, specifically melanoma.